RCUS Message Board Post 9986362 | Arcus Biosciences Inc.
home / stock / rcus / rcus message board
vbooker0732
(investorshub)
Posted on: Apr/20/2020 17:47:24
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155137742
RCUS getting ready to pop to 33-35 dollars.
News, Short Squeeze, Breakout and More Instantly...
-
Domvanalimab is the only anti-TIGIT antibody in Phase 3 for upper gastrointestinal (GI) adenocarcinomas with the potential to be first-to-market for this patient population Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing di...
-
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 45 th Annual ...
-
2024-06-04 14:00:07 ET Peter Lawson from Barclays issued a price target of $35.00 for RCUS on 2024-06-04 09:49:00. The adjusted price target was set to $35.00. At the time of the announcement, RCUS was trading at $16.15. The overall price target consensus is at $42.00 wi...